AXSM Maintained by Piper Sandler -- Price Target Lowered to $238

gurufocus.com · 2026-10-26

On October 26, 2026, analyst Piper Sandler maintained an "Overweight" rating on Axsome Therapeutics (AXSM), while lowering its price target from $258 to $238, r

Read the full story at gurufocus.com →